Your browser doesn't support javascript.
loading
Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia.
Batrani, Meenakshi; Salhotra, Manish; Kubba, Asha; Agrawal, Manjul.
Affiliation
  • Batrani M; Delhi Dermpath Laboratory, Delhi Dermatology Group, New Delhi, India.
  • Salhotra M; Department of Pathology, Rao Tula Ram Hospital, New Delhi, India.
  • Kubba A; Delhi Dermpath Laboratory, Delhi Dermatology Group, New Delhi, India.
  • Agrawal M; Department of Dermatology, Fortis Hospital, New Delhi, India.
Indian J Dermatol Venereol Leprol ; 82(6): 727-729, 2016.
Article in En | MEDLINE | ID: mdl-27716725
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Porphyrias / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Imatinib Mesylate / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Aged / Female / Humans Language: En Journal: Indian J Dermatol Venereol Leprol Year: 2016 Document type: Article Affiliation country: India
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Porphyrias / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Imatinib Mesylate / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Aged / Female / Humans Language: En Journal: Indian J Dermatol Venereol Leprol Year: 2016 Document type: Article Affiliation country: India